SwePub
Sök i LIBRIS databas

  Extended search

L773:1872 6216 OR L773:0047 6374
 

Search: L773:1872 6216 OR L773:0047 6374 > Coenzyme Q(10) supp...

  • Aaseth, JanInnlandet Hosp Trust, Norway (author)

Coenzyme Q(10) supplementation - In ageing and disease

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • Elsevier Ireland Ltd,2021
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-179940
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-179940URI
  • https://doi.org/10.1016/j.mad.2021.111521DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Norwegian Institute of Public Health, Norway; Innlandet Hospital Trust, Norway
  • Coenzyme Q(10) (CoQ(10)) is an essential component of the mitochondrial electron transport chain. It is also an antioxidant in cellular membranes and lipoproteins. All cells produce CoQ(10) by a specialized cytoplasmatic-mitochondrial pathway. CoQ(10) deficiency can result from genetic failure or ageing. Some drugs including statins, widely used by inter alia elderly, may inhibit endogenous CoQ(10) synthesis. There are also chronic diseases with lower levels of CoQ(10) in tissues and organs. High doses of CoQ(10) may increase both circulating and intracellular levels, but there are conflicting results regarding bioavailability. Here, we review the current knowledge of CoQ(10) biosynthesis and primary and acquired CoQ(10) deficiency, and results from clinical trials based on CoQ(10) supplementation. There are indications that supplementation positively affects mitochondrial deficiency syndrome and some of the symptoms of ageing. Cardiovascular disease and inflammation appear to be alleviated by the antioxidant effect of CoQ(10). There is a need for further studies and well-designed clinical trials, with CoQ(10) in a formulation of proven bioavailability, involving a greater number of participants undergoing longer treatments in order to assess the benefits of CoQ(10) treatment in neurodegenerative disorders, as well as in metabolic syndrome and its complications.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Alexander, JanNorwegian Inst Publ Hlth, Norway (author)
  • Alehagen, UrbanLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten(Swepub:liu)urbal84 (author)
  • Innlandet Hosp Trust, NorwayNorwegian Inst Publ Hlth, Norway (creator_code:org_t)

Related titles

  • In:Mechanisms of Ageing and Development: Elsevier Ireland Ltd1970047-63741872-6216

Internet link

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Aaseth, Jan
Alexander, Jan
Alehagen, Urban
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Neurology
Articles in the publication
Mechanisms of Ag ...
By the university
Linköping University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view